Brohult J, Hedman P, Rombo L, Sirleaf V, Bengtsson E
Ann Trop Med Parasitol. 1979 Aug;73(4):327-31. doi: 10.1080/00034983.1979.11687266.
In a West African community approximately 80% of the non-African personnel were taking malaria prophylactics in the recommended manner. The non-takers stated that they were afraid of side-effects of the drugs and/or under-estimated the risks of the disease. During one year 123 patients with clinically suspected malaria were studied. All patients with positive slides were cured with regular dose of 1.5 g chloroquine base. No chloroquine resistance was therefore demonstrated, although 4-aminoquinoline prophylaxis had been given for almost 20 years to thousands of non-African non-immunes as well as in pregnant women and children in the town. Common reasons for 'breakdowns' were febrile disease other than malaria, false positive diagnosis and improper chemoprophylaxis.
在一个西非社区,约80%的非非洲籍人员按推荐方式服用疟疾预防药物。未服药者表示,他们害怕药物的副作用和/或低估了患病风险。在一年时间里,对123例临床疑似疟疾患者进行了研究。所有血片检测呈阳性的患者均用1.5克氯喹碱基常规剂量治愈。因此,尽管已对镇上数千名非非洲籍非免疫人群以及孕妇和儿童使用4-氨基喹啉预防近20年,但未发现氯喹耐药情况。“治疗失败”的常见原因是除疟疾外的发热性疾病、假阳性诊断和不适当的化学预防。